ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 120 filers reported holding ANIKA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,560,661 | -37.9% | 244,802 | -13.4% | 0.00% | -100.0% |
| Q2 2023 | $7,340,195 | -1.9% | 282,532 | +8.5% | 0.00% | 0.0% |
| Q1 2023 | $7,479,479 | +31.4% | 260,427 | +35.4% | 0.00% | 0.0% |
| Q4 2022 | $5,693,234 | -66.3% | 192,339 | -72.9% | 0.00% | -50.0% |
| Q3 2022 | $16,914,000 | +13.0% | 710,688 | +6.0% | 0.00% | 0.0% |
| Q2 2022 | $14,968,000 | -6.0% | 670,562 | +5.7% | 0.00% | 0.0% |
| Q1 2022 | $15,925,000 | -35.7% | 634,245 | -8.3% | 0.00% | -33.3% |
| Q4 2021 | $24,782,000 | +2.9% | 691,659 | +22.2% | 0.00% | 0.0% |
| Q3 2021 | $24,082,000 | -1.4% | 565,846 | +0.3% | 0.00% | 0.0% |
| Q2 2021 | $24,425,000 | -8.4% | 564,212 | -13.7% | 0.00% | -25.0% |
| Q1 2021 | $26,661,000 | +505.5% | 653,633 | +571.9% | 0.00% | +300.0% |
| Q4 2020 | $4,403,000 | +5.7% | 97,284 | -17.3% | 0.00% | 0.0% |
| Q3 2020 | $4,165,000 | +89.3% | 117,676 | +101.8% | 0.00% | – |
| Q2 2020 | $2,200,000 | +34.6% | 58,327 | +3.1% | 0.00% | – |
| Q1 2020 | $1,635,000 | -80.8% | 56,553 | -65.6% | 0.00% | -100.0% |
| Q4 2019 | $8,522,000 | -5.9% | 164,360 | -0.3% | 0.00% | 0.0% |
| Q3 2019 | $9,054,000 | +2.1% | 164,932 | -24.5% | 0.00% | 0.0% |
| Q2 2019 | $8,872,000 | +99.6% | 218,413 | +48.6% | 0.00% | +100.0% |
| Q1 2019 | $4,444,000 | +119.9% | 146,941 | +144.3% | 0.00% | 0.0% |
| Q4 2018 | $2,021,000 | -43.7% | 60,137 | -29.3% | 0.00% | 0.0% |
| Q3 2018 | $3,588,000 | -77.7% | 85,063 | -83.1% | 0.00% | -75.0% |
| Q2 2018 | $16,077,000 | +357.6% | 502,400 | +611.0% | 0.00% | +300.0% |
| Q1 2018 | $3,513,000 | -11.1% | 70,662 | -3.6% | 0.00% | 0.0% |
| Q4 2017 | $3,953,000 | -1.2% | 73,314 | +6.2% | 0.00% | 0.0% |
| Q3 2017 | $4,002,000 | +101.7% | 69,010 | +71.6% | 0.00% | 0.0% |
| Q2 2017 | $1,984,000 | -74.7% | 40,210 | -77.7% | 0.00% | 0.0% |
| Q1 2017 | $7,828,000 | -11.0% | 180,206 | +0.3% | 0.00% | 0.0% |
| Q4 2016 | $8,792,000 | +114.8% | 179,600 | +109.9% | 0.00% | 0.0% |
| Q3 2016 | $4,094,000 | -13.3% | 85,554 | -2.8% | 0.00% | -50.0% |
| Q2 2016 | $4,720,000 | -21.9% | 87,984 | -34.9% | 0.00% | 0.0% |
| Q1 2016 | $6,042,000 | +26.2% | 135,094 | +7.7% | 0.00% | 0.0% |
| Q4 2015 | $4,788,000 | +68.1% | 125,473 | +40.2% | 0.00% | +100.0% |
| Q3 2015 | $2,848,000 | -6.0% | 89,467 | -2.5% | 0.00% | 0.0% |
| Q2 2015 | $3,030,000 | +16.9% | 91,751 | +45.7% | 0.00% | 0.0% |
| Q1 2015 | $2,592,000 | +57.1% | 62,968 | +55.5% | 0.00% | 0.0% |
| Q4 2014 | $1,650,000 | -71.8% | 40,503 | -74.6% | 0.00% | -50.0% |
| Q3 2014 | $5,856,000 | +14.6% | 159,757 | +44.9% | 0.00% | 0.0% |
| Q2 2014 | $5,108,000 | +52.5% | 110,248 | +35.3% | 0.00% | +100.0% |
| Q1 2014 | $3,349,000 | -17.4% | 81,494 | -23.3% | 0.00% | -50.0% |
| Q4 2013 | $4,053,000 | -1.2% | 106,219 | -38.1% | 0.00% | 0.0% |
| Q3 2013 | $4,103,000 | +476.3% | 171,711 | +309.8% | 0.00% | – |
| Q2 2013 | $712,000 | – | 41,899 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 44,875 | $2,031,000 | 2.14% |
| Parian Global Management LP | 102,705 | $4,648,000 | 1.16% |
| CAPITAL MANAGEMENT CORP /VA | 93,035 | $4,211,000 | 1.15% |
| Avidity Partners Management LP | 731,000 | $33,085,000 | 1.07% |
| Sio Capital Management, LLC | 65,382 | $2,959,000 | 0.61% |
| DIKER MANAGEMENT LLC | 21,835 | $988,000 | 0.50% |
| Archon Capital Management LLC | 48,925 | $2,214,000 | 0.38% |
| Caption Management, LLC | 362,800 | $16,420,000 | 0.37% |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,546,260 | $69,984,000 | 0.20% |
| Boston Trust Walden Corp | 378,167 | $17,116,000 | 0.18% |